Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134628) titled 'Clinical study to evaluate the imaging effect of [68Ga]Ga-ELI30104 injection in patients with primary hepatocellular carcinoma' on Oct. 19.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: The First Affiliated Hospital of Guilin Medical University
Condition:
primary hepatocellular carcinoma (HCC)
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-11-02
Target Sample Size: [68Ga]Ga-ELI30104 group:4;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=347998
Disclaimer: Curated by HT Syndication....